scholarly journals Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

Diabetes ◽  
2015 ◽  
Vol 64 (7) ◽  
pp. 2398-2408 ◽  
Author(s):  
Gijs den Besten ◽  
Aycha Bleeker ◽  
Albert Gerding ◽  
Karen van Eunen ◽  
Rick Havinga ◽  
...  
Metabolites ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. 456
Author(s):  
Mihai V. Curtasu ◽  
Valeria Tafintseva ◽  
Zachary A. Bendiks ◽  
Maria L. Marco ◽  
Achim Kohler ◽  
...  

The metabolome and gut microbiota were investigated in a juvenile Göttingen minipig model. This study aimed to explore the metabolic effects of two carbohydrate sources with different degrees of risk in obesity development when associated with a high fat intake. A high-risk (HR) high-fat diet containing 20% fructose was compared to a control lower-risk (LR) high-fat diet where a similar amount of carbohydrate was provided as a mix of digestible and resistant starch from high amylose maize. Both diets were fed ad libitum. Non-targeted metabolomics was used to explore plasma, urine, and feces samples over five months. Plasma and fecal short-chain fatty acids were targeted and quantified. Fecal microbiota was analyzed using genomic sequencing. Data analysis was performed using sparse multi-block partial least squares regression. The LR diet increased concentrations of fecal and plasma total short-chain fatty acids, primarily acetate, and there was a higher relative abundance of microbiota associated with acetate production such as Bacteroidetes and Ruminococcus. A higher proportion of Firmicutes was measured with the HR diet, together with a lower alpha diversity compared to the LR diet. Irrespective of diet, the ad libitum exposure to the high-energy diets was accompanied by well-known biomarkers associated with obesity and diabetes, particularly branched-chain amino acids, keto acids, and other catabolism metabolites.


2019 ◽  
Vol 20 (19) ◽  
pp. 4738 ◽  
Author(s):  
Yiqiong Yuan ◽  
Qibing Liu ◽  
Fuqiang Zhao ◽  
Jun Cao ◽  
Xuanri Shen ◽  
...  

Holothuria leucospilota polysaccharides (HLP) are expected to become potential resources for the treatment of hyperlipidemia because of their various bioactivities. In the study, the treatment of HLP on improving hyperlipidemia in rats was explored. Oral administration of HLP at 100 or 200 mg/kg body weight effectively alleviated serum lipid levels and liver histological abnormalities in high-fat-diet rats. HLP regulated abnormal mRNA, lipogenesis-related hormones and inflammatory cytokines (tumor necrosis factor-α, interleukin-6 and interleukin-12) levels. HLP improved the ability of gut microbiota to produce short-chain fatty acids (SCFAs). SCFAs have been found to ameliorate liver lesions. Therefore, HLP alleviated hyperlipidemia by improving the levels of SCFAs to regulate lipid metabolism. These results indicated that HLP could be used as beneficial polysaccharides to alleviate hyperlipidemia.


2018 ◽  
Vol 48 ◽  
pp. 266-274 ◽  
Author(s):  
Ângela Giovana Batista ◽  
Juliana Kelly da Silva-Maia ◽  
Monique Culturato P. Mendonça ◽  
Edilene Siqueira Soares ◽  
Glaucia Carielo Lima ◽  
...  

2019 ◽  
Vol 84 (12) ◽  
pp. 3833-3842 ◽  
Author(s):  
Yiming Zhou ◽  
Qingyi Jiang ◽  
Shen Zhao ◽  
Beibei Yan ◽  
Xiaoli Zhou

PLoS ONE ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. e0196579 ◽  
Author(s):  
Junki Miyamoto ◽  
Keita Watanabe ◽  
Satsuki Taira ◽  
Mayu Kasubuchi ◽  
Xuan Li ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Karolin Weitkunat ◽  
Christin Stuhlmann ◽  
Anna Postel ◽  
Sandra Rumberger ◽  
Maria Fankhänel ◽  
...  

2020 ◽  
Vol 145 ◽  
pp. 1066-1072
Author(s):  
Carolyne Pimentel Rosado ◽  
Victor Hugo Cordeiro Rosa ◽  
Bruna Cadete Martins ◽  
Aruanna Cajaty Soares ◽  
Izabelle Barcellos Santos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document